Brokerages Set Trupanion, Inc. (NASDAQ:TRUP) Price Target at $44.67

Trupanion, Inc. (NASDAQ:TRUP) has been given an average rating of “Moderate Buy” by the seven research firms that are presently covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. The average 12-month target price among brokers that have covered the stock in the last year is $44.67.

A number of analysts recently issued reports on the company. Northland Securities increased their price objective on Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a report on Thursday, October 31st. Piper Sandler increased their price target on shares of Trupanion from $45.00 to $57.00 and gave the stock a “neutral” rating in a report on Thursday, October 31st. Stifel Nicolaus raised their price objective on shares of Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a research report on Monday, September 23rd. Finally, Bank of America upped their target price on shares of Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a report on Friday, September 20th.

Insider Transactions at Trupanion

In related news, CFO Fawwad Qureshi sold 622 shares of the company’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $52.61, for a total value of $32,723.42. Following the completion of the transaction, the chief financial officer now directly owns 9,867 shares in the company, valued at approximately $519,102.87. The trade was a 5.93 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Murray B. Low sold 2,000 shares of the firm’s stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $52.67, for a total value of $105,340.00. Following the sale, the director now owns 131,513 shares in the company, valued at $6,926,789.71. The trade was a 1.50 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 28,405 shares of company stock valued at $1,512,482. 5.50% of the stock is owned by corporate insiders.

Institutional Trading of Trupanion

Hedge funds have recently bought and sold shares of the company. FMR LLC raised its stake in shares of Trupanion by 55,963.7% during the third quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock worth $49,213,000 after acquiring an additional 1,170,202 shares in the last quarter. Renaissance Technologies LLC bought a new position in shares of Trupanion during the 2nd quarter valued at $4,739,000. Marshall Wace LLP raised its position in Trupanion by 11.9% in the 2nd quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock worth $32,181,000 after purchasing an additional 116,496 shares during the period. Connors Investor Services Inc. lifted its stake in Trupanion by 31.3% in the second quarter. Connors Investor Services Inc. now owns 113,567 shares of the financial services provider’s stock worth $3,339,000 after purchasing an additional 27,042 shares during the last quarter. Finally, Dalton Investments Inc. purchased a new stake in Trupanion during the second quarter valued at about $1,029,000.

Trupanion Stock Performance

NASDAQ TRUP opened at $54.15 on Friday. The company’s 50 day moving average is $52.58 and its 200-day moving average is $42.26. The firm has a market cap of $2.29 billion, a P/E ratio of -169.22 and a beta of 1.60. Trupanion has a 12-month low of $19.69 and a 12-month high of $57.90. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.40.

Trupanion (NASDAQ:TRUP) last issued its earnings results on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.09. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. The business had revenue of $327.50 million for the quarter, compared to analysts’ expectations of $321.79 million. During the same quarter in the previous year, the firm posted ($0.10) EPS. The business’s revenue for the quarter was up 14.6% compared to the same quarter last year. Sell-side analysts predict that Trupanion will post -0.23 earnings per share for the current year.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.